Firms “Under-invest” in Long-Term Cancer Research

News   Jul 30, 2015

 
Firms “Under-invest” in Long-Term Cancer Research
 
 
 

RELATED ARTICLES

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

Unchained Labs Unveils LEA 9 Software Making Workflows Easy

News

Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, released its LEA 9 software, making Freeslate and Junior automation systems way more accessible.

READ MORE

$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

News

ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE